Cargando…
Targeting Host Innate and Adaptive Immunity to Achieve the Functional Cure of Chronic Hepatitis B
Despite the availability of an effective preventive vaccine for hepatitis B virus (HBV) for over 38 years, chronic HBV (CHB) infection remains a global health burden with around 257 million patients. The ideal treatment goal for CHB infection would be to achieve complete cure; however, current thera...
Autores principales: | Ezzikouri, Sayeh, Hoque Kayesh, Mohammad Enamul, Benjelloun, Soumaya, Kohara, Michinori, Tsukiyama-Kohara, Kyoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349973/ https://www.ncbi.nlm.nih.gov/pubmed/32403281 http://dx.doi.org/10.3390/vaccines8020216 |
Ejemplares similares
-
Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview
por: Kayesh, Mohammad Enamul Hoque, et al.
Publicado: (2021) -
Epidemiology and Risk Factors for Acute Viral Hepatitis in Bangladesh: An Overview
por: Kayesh, Mohammad Enamul Hoque, et al.
Publicado: (2022) -
Toll-like Receptor Response to Hepatitis C Virus Infection: A Recent Overview
por: Kayesh, Mohammad Enamul Hoque, et al.
Publicado: (2022) -
Toll-like Receptor Response to Human Immunodeficiency Virus Type 1 or Co-Infection with Hepatitis B or C Virus: An Overview
por: Kayesh, Mohammad Enamul Hoque, et al.
Publicado: (2023) -
Recent Insights Into the Molecular Mechanism of Toll-Like Receptor Response to Dengue Virus Infection
por: Kayesh, Mohammad Enamul Hoque, et al.
Publicado: (2021)